Skip to search boxSkip to navigationSkip to main content

The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination

  • Jean Paul Kovalik
    ,
  • ,
  • Sanjeev K. Mendiratta
    ,
  • W. David Martin
    ,
  • Leszek Ignatowicz
    ,
  • Luc Van Kaer(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

The cellular basis for allograft rejection derives from the strong T cell response to cells bearing foreign MHC. While it was originally assumed that alloreactive T cells focus their recognition on the polymorphic residues that differ between syngeneic and allogeneic MHC molecules, studies with MHC class I-restricted CTL have shown that MHC-bound peptides play a critical role in allorecognition. It has been suggested that alloreactive T cells depend more strongly on interactions with the MHC molecule than with the associated peptide, but there is little evidence to support this idea. Here we have studied the alloreactive and self-restricted response directed against the class II H2-A(b) molecule bound with a single peptide, Ep, derived from the H2-Eα chain. This MHC class II-peptide combination was a poor target and stimulator of alloreactive CD4+ T cell responses, indicating that MHC-bound peptides are as important for alloreactive CD4+ T cells as they are for alloreactive CTL. We also generated alloreactive T cells with exquisite specificity for the A(b)/Ep complex, and compared their reactivity with self-restricted T cells specific for the same A(b)/Ep complex. Our results showed that peptide-specific alloreactive T cells, as compared with self-restricted T cells, were more sensitive to peptide stimulation, but equally sensitive to amino acid substitutions in the peptide. These findings indicate that alloreactive and self-restricted T cells interact similarly with their MHC/peptide ligand.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1285-1293 (9 pages)

Journal (Volume, Issue Number)

Journal of Immunology (Volume 165, Issue 3)

Publication milestones

  • Published - 08/01/2000

Publication status

Published - 08/01/2000

ISSN

0022-1767

Publication IDs

  • Scopus: 0034254298
  • PubMed: 10903728

Publication metrics

Metrics

Scopus
citations
Fractional count
2
Fractional count
0.33
Fractional count
4
Fractional count
0.67
Fractional count
2
Fractional count
1
SciVal
citations
14
SciVal
FWCI
0.45
SciVal
Author count
6
SciVal
Paper percentile
62

PlumX, opens in new tab

Citation count
15
Captures
5

Funding Details

FunderFunding number
NIGMS
T32GM007347